about
Performance of CHROMAGAR candida and BIGGY agar for identification of yeast speciesIdentification of Candida species in the oral cavity of diabetic patients.Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprintingEvaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida speciesPractical bench comparison of BBL CHROMagar Orientation and standard two-plate media for urine cultures.Yeast identification--past, present, and future methods.Production of white colonies on CHROMagar Candida medium by members of the Candida glabrata clade and other species with overlapping phenotypic traitsIncidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.Identification of Candida glabrata by a 30-second trehalase test.Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida.Rapid identification of Candida glabrata with a new commercial test, GLABRATA RTTIdentifying Candida and other yeast-like fungi: utility of an identification algorithm in resource limited setting.COMPARISON BETWEEN FOUR USUAL METHODS OF IDENTIFICATION OF Candida SPECIES.Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories.Discrimination between Candida albicans and Candida dubliniensis isolated from HIV-positive patients by using commercial method in comparison with PCR assay.Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods.Antifungal susceptibility in vitro determined by the Etest® for Candida obtained from the oral cavity of irradiated and elderly individuals.The effect of complete dentures with a metal palate on candida species growth in HIV-infected patients.Use of Dermasilk briefs in recurrent vulvovaginal candidosis: safety and effectiveness
P2860
Q24797201-AC671881-F324-4027-83AB-5313717081A7Q33851323-59057F72-8033-4D65-A4DF-1343268A1645Q34041713-B33443A3-99BC-4466-9343-B8A26526DE79Q35073427-FB929272-94E4-4E3B-9A1E-F7BC2ADAFF0EQ35552854-D815FC80-1758-4004-A611-803B4DD20D1BQ36761938-12D9C274-3B79-410F-B718-A39B7320D8B7Q36933401-680E0E69-311D-4544-8BDA-78A8E8D335DCQ37420953-8A8CE1F0-4DAD-4278-9222-BDBBA4AE8BD6Q39664961-250FC538-CAF3-4A57-8D4F-DC42B40F304AQ39758166-A3F5BB48-74F7-4FCD-9349-0BBC0BF7A0C0Q39848366-1F47D8F7-37D7-46A1-A6C6-F45FC50C7144Q41501941-CFF9048D-938E-4766-B7A5-3845140EFDFAQ41995887-B980ED26-87E4-4B20-9B6D-1E380C2F7910Q43010987-8BB456D1-9177-4CBE-8439-4770ABECBF44Q43533023-AD414D71-398B-4C22-AF54-03B14A2B2E54Q44658393-1DCF2BE1-5992-4293-8521-DEB5431E54FCQ46750212-A6661EAF-AE31-4D0C-8EDE-9B6CE0EFE720Q51135942-FBF163F6-BB5D-478A-85BC-4F737B81ED16Q56981845-65911128-706F-4C81-8311-3ACF24AF8B77
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Evaluation of a reformulated CHROMagar Candida.
@ast
Evaluation of a reformulated CHROMagar Candida.
@en
type
label
Evaluation of a reformulated CHROMagar Candida.
@ast
Evaluation of a reformulated CHROMagar Candida.
@en
prefLabel
Evaluation of a reformulated CHROMagar Candida.
@ast
Evaluation of a reformulated CHROMagar Candida.
@en
P2093
P2860
P1476
Evaluation of a reformulated CHROMagar Candida.
@en
P2093
M A Jabra-Rizk
M Romagnoli
T F Meiller
T M Brenner
W A Falkler
P2860
P304
P356
10.1128/JCM.39.5.2015-2016.2001
P407
P577
2001-05-01T00:00:00Z